Dr. Douglas Katz discusses the Neurology Journal article, "National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome".

Show references: https://n.neurology.org/content/early/2021/03/15/WNL.0000000000011850

Dr. Adam de Havenon discusses the Neurology Journal article, "Five-Year Trends in Payments for Neurologist-Prescribed Drugs in Medicare Part D".

Show references: https://n.neurology.org/content/96/16/e2132

Dr. Ilana Breen discusses her abstract, "Calcitonin Gene-Related Peptide Inhibitor Use for Migraine Associated with Exacerbation of Raynaud Phenomenon".

You can view her abstract and others here: https://index.mirasmart.com/AAN2021/

Dr. Hena Waseem discusses her abstract, "Safety and Efficacy of the Telestroke Drip-and-Stay Model: A systematic review and meta-analysis".

You can view her abstract and others here: https://index.mirasmart.com/AAN2021/

In part 2 of a 2-part series, Derek Brandt, Director, Congressional Affairs at the American Academy of Neurology, shares about funding for medical research in the U.S.

In part 1 of a 2-part series, Derek Brandt, Director, Congressional Affairs at the American Academy of Neurology, shares about the Veterans Affairs Centers of Excellence.

Dr. Peter Marks discusses the Johnson & Johnson COVID-19 vaccine.

Professor Maria Eriksdotter discusses whether Cholinesterase inhibitors are associated with slower cognitive decline and decreased mortality risk.

Dr. Martijn Wijburg discusses pharmacovigilance of patients treated with disease-modifying therapies for MS.

Show references:

https://pubmed.ncbi.nlm.nih.gov/33229453/

Dr. Sabrina Paganoni discusses her abstract, "Long-Term Survival of Participants in the CENTAUR Trial of AMX0035 for ALS".

You can view her abstract and others here: https://index.mirasmart.com/AAN2021/